Beneficial effects of perhexiline in cardiovascular disease states / / Yuliy Y. Chirkov, Aaron L. Sverdlov and John D. Horowitz
(Visualizza in formato marc)
(Visualizza in BIBFRAME)
| Autore: |
Chirkov Yuliy Y
|
| Titolo: |
Beneficial effects of perhexiline in cardiovascular disease states / / Yuliy Y. Chirkov, Aaron L. Sverdlov and John D. Horowitz
|
| Pubblicazione: | New York, : Nova Biomedical/Nova Science Publishers, 2010 |
| Edizione: | 1st ed. |
| Descrizione fisica: | 1 online resource (53 p.) |
| Disciplina: | 616.1/22061 |
| Soggetto topico: | Perhexiline - Therapeutic use |
| Angina pectoris - Chemotherapy | |
| Cardiovascular agents | |
| Altri autori: |
SverdlovAaron L
HorowitzJohn D
|
| Note generali: | Description based upon print version of record. |
| Nota di bibliografia: | Includes bibliographical references (p. [31]-38) and index. |
| Nota di contenuto: | Clinical applications of perhexiline -- Pharmacokinetics and toxicity of perhexiline -- Pharmacology of perhexiline -- Conclusion and future perspectives. |
| Sommario/riassunto: | Perhexiline, 2-(2,2-dicyclohexylethyl) piperidine, was originally developed as a prophylactic anti-anginal drug in the late 1960s. This book discusses the benefits of perhexiline in the treatment of cardiovascular disease. |
| Titolo autorizzato: | Beneficial effects of perhexiline in cardiovascular disease states |
| ISBN: | 1-61728-630-3 |
| Formato: | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione: | Inglese |
| Record Nr.: | 9910965123103321 |
| Lo trovi qui: | Univ. Federico II |
| Opac: | Controlla la disponibilità qui |
Serie:
Cardiology research and clinical developments series.